home.social
Sign in Create account

#stockdrop — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #stockdrop, aggregated by home.social.

  1. TECHi @[email protected] ·

    Intel’s Q2 earnings revealed a $2.1B loss and plans to cut 15% of its global workforce, sending shares down 8.5%. Despite stable revenue, shrinking margins, canceled chip plants, and weak AI traction have investors worried. New CEO Lip-Bu Tan is pushing strict cost-cutting, but Intel’s future remains uncertain.

    #Intel #Layoffs #EarningsReport #ChipMarket #Semiconductors #AIChips #INTC #TechNews #StockDrop
    #TECHi

    Read Full Article Here :- techi.com/intel-stock-drops-af

    #intel #layoffs #earningsreport #chipmarket #semiconductors #aichips
  2. Yonhap Infomax News @[email protected] ·

    Novo Nordisk shares tumbled over 5% after new obesity drug data disappointed investors, intensifying concerns that Eli Lilly could dominate the fast-growing weight-loss treatment market.
    #YonhapInfomax #NovoNordisk #EliLilly #ObesityDrug #CagriSema #StockDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #novonordisk #elililly #obesitydrug #cagrisema #stockdrop
  3. Yonhap Infomax News @[email protected] ·

    Novo Nordisk shares tumbled over 5% after new obesity drug data disappointed investors, intensifying concerns that Eli Lilly could dominate the fast-growing weight-loss treatment market.
    #YonhapInfomax #NovoNordisk #EliLilly #ObesityDrug #CagriSema #StockDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #novonordisk #elililly #obesitydrug #cagrisema #stockdrop
  4. Yonhap Infomax News @[email protected] ·

    Novo Nordisk shares tumbled over 5% after new obesity drug data disappointed investors, intensifying concerns that Eli Lilly could dominate the fast-growing weight-loss treatment market.
    #YonhapInfomax #NovoNordisk #EliLilly #ObesityDrug #CagriSema #StockDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #novonordisk #elililly #obesitydrug #cagrisema #stockdrop
  5. Yonhap Infomax News @[email protected] ·

    Novo Nordisk shares tumbled over 5% after new obesity drug data disappointed investors, intensifying concerns that Eli Lilly could dominate the fast-growing weight-loss treatment market.
    #YonhapInfomax #NovoNordisk #EliLilly #ObesityDrug #CagriSema #StockDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #stockmarket #bonds #securities #banking #financialmarkets #economics
  6. Yonhap Infomax News @[email protected] ·

    Novo Nordisk shares tumbled over 5% after new obesity drug data disappointed investors, intensifying concerns that Eli Lilly could dominate the fast-growing weight-loss treatment market.
    #YonhapInfomax #NovoNordisk #EliLilly #ObesityDrug #CagriSema #StockDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #novonordisk #elililly #obesitydrug #cagrisema #stockdrop
  7. Yonhap Infomax News @[email protected] ·

    Super Micro Computer's stock tumbles 9% as Q4 earnings guidance disappoints investors, raising concerns about AI server market growth
    #YonhapInfomax #SuperMicroComputer #EarningsGuidance #AIServer #StockDrop #WallStreetEstimates #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #supermicrocomputer #earningsguidance #aiserver #stockdrop #wallstreetestimates